Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
317.79
Molecular Formula
C12H16ClN3O3S
Notes
Research use only, not for human use.
Receptor
Α1A-adrenergic receptor
CAS Number
219311-44-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
